Shares of Karuna Therapeutics Inc. KRTX, more than tripled (up 254%) November 19th in active trading to an intraday high of $123.99 after a phase 2 trial of its schizophrenia treatment met…
This investment is available for qualified clients only
I acknowledge that I will have at least $1 million of assets under management with the General Partner or that I have a net worth of $2.1 million or more exclusive of my residence.